Canaan Partners has 37 tracked deals to Goldman Sachs's 27. Stage focus, check size, and sector fit compared side by side.
Canaan Partners is a venture capital based in Israel with 37 tracked deals. Goldman Sachs is a accelerator based in Chicago, IL, United States with 27 tracked deals. Canaan Partners shows 10 more tracked rounds than Goldman Sachs in this dataset, which is the clearest signal of deployment pace between the two. Sector focus diverges: Canaan Partners concentrates on Artificial Intelligence, Digital Health and SaaS and Goldman Sachs on generalist deals. On stage, Canaan Partners is active at Seed and Goldman Sachs at undisclosed stages. Recent tracked names include Actio Biosciences and Aim Security for Canaan Partners and Alterome Therapeutics and Amount for Goldman Sachs.
Investors like Canaan Partners · Investors like Goldman Sachs · Canaan Partners co-investors · Full investor directory